Allantoin activates imidazoline I-3 receptors to enhance insulin secretion in pancreatic β-cells

BackgroundImidazoline I3 receptors (I-3R) can regulate insulin secretion in pancreatic β-cells. It has been indicated that allantoin ameliorates hyperglycemia by activating imidazoline I2 receptors (I-2R). Thus, the effect of allantoin on I-3R is identified in the present study.MethodsWe used male Wistar rats to screen allantoin’s ability for lowering of blood glucose and stimulation of insulin secretion. Chinese hamster ovary-K1 cells transfected with imidazoline receptors (NISCH-CHO-K1 cells) were also applied to characterize the direct effect of allantoin on this receptor. Additionally, KU14R as specific antagonist was treated to block I-3R in rats and in the cultured pancreatic β-cells named Min 6 cells.ResultsIn rats, allantoin decreased blood sugar with an increase in plasma insulin. Also, allantoin enhanced calcium influx into NISCH-CHO-K1 cells in a way similar to agmatine, an I-R agonist. Moreover, KU14R dose-dependently blocked allantoin-induced insulin secretion both in Min 6 cells and in Wistar rats.ConclusionAllantoin can activate I-3R to enhance insulin secretion for lowering of blood sugar in Wistar rats. Thus, allantoin may provide beneficial effects as a supplement for diabetic patients after clinical trials.

• Publication year

  2014

• Venue

  Nutrition and Metabolism

• Publication date

  2014-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1743-7075-11-41
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Antihypertensive Action of Allantoin in Animals

  2014cited by this paper
• Improvement of Obesity by Activation of I1-Imidazoline Receptors in High Fat Diet-fed Mice

  2013cited by this paper
• Botulinum toxin for meralgia paresthetica in type 2 diabetes.

  2013cited by this paper
• TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

  2013cited by this paper
• Decrease of Obesity by Allantoin via Imidazoline I1-Receptor Activation in High Fat Diet-Fed Mice

  2013cited by this paper
• [Imidazoline receptor agonists: are they actual today?].

  2012cited by this paper
• Targeting PDEs for Treating Metabolic Disease: Lessons from Resveratrol

  2012cited by this paper
• Cyclic AMP Prevents Hypoxia-Induced Arginase II Expression and Proliferation of Human Pulmonary Artery Smooth Muscle Cells; However, Mice Deficient in PDE3A have Evidence of Pulmonary Hypertension

  2012cited by this paper
• Activation of Imidazoline I-2B Receptors by Allantoin to Increase Glucose Uptake into C2C12 Cells

  2012cited by this paper
• High Passage MIN6 Cells Have Impaired Insulin Secretion with Impaired Glucose and Lipid Oxidation

  2012cited by this paper
• Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell line

  2012cited by this paper
• [Imidazoline receptor agonists: are they actual today?].

  2012cited by this paper
• Improvement of Hyperphagia by Activation of Cerebral I1-Imidazoline Receptors in Streptozotocin-induced Diabetic Mice

  2012cited by this paper
• G-Protein-Coupled Receptor-Mediated MAPK and PI3-Kinase Signaling Is Maintained in Chinese Hamster Ovary Cells after γ-Irradiation

  2012cited by this paper
• Stimulatory Effect of Allantoin on Imidazoline I1 Receptors in Animal and Cell Line

  2012cited by this paper
• Plasma Glucose-lowering Action of Allantoin is Induced by Activation of Imidazoline I-2 Receptors in Streptozotocin-induced Diabetic Rats

  2011cited by this paper
• Nutrition/Metabolism

  2011cited by this paper
• Metformin can Activate Imidazoline I-2 Receptors to Lower Plasma Glucose in Type 1-like Diabetic Rats

  2010cited by this paper
• Activation of imidazoline I2B receptors is linked with AMP kinase pathway to increase glucose uptake in cultured C2C12 cells.

  2010cited by this paper
• Decrease of plasma glucose by allantoin, an active principle of yam ( Dioscorea spp.), in streptozotocin-induced diabetic rats.

  2010influential reference
• ncrease of-endorphin secretion by agmatine is induced by activation of midazoline I 2 A receptors in adrenal gland of rats hin -

  2009cited by this paper
• TRPM4 impacts on Ca2+ signals during agonist-induced insulin secretion in pancreatic beta-cells.

  2009cited by this paper
• DHEA improves impaired activation of Akt and PKC ζ/λ‐GLUT4 pathway in skeletal muscle and improves hyperglycaemia in streptozotocin‐induced diabetes rats

  2009cited by this paper
• streptozotocin- induced diabetic rats

  2008cited by this paper
• [Imidazoline receptor].

  2008cited by this paper
• Dioscorea as the principal herb of Die-Huang-Wan, a widely used herbal mixture in China, for improvement of insulin resistance in fructose-rich chow-fed rats.

  2007cited by this paper
• VASODILATATION INDUCED BY SINOMENINE LOWERS BLOOD PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS

  2007cited by this paper
• Dioscorea opposita reverses dexamethasone induced insulin resistance.

  2007cited by this paper
• Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway.

  2007cited by this paper
• Characterization of new starches separated from different Chinese yam (Dioscorea opposita Thunb.) cultivars

  2006cited by this paper
• Biological functions of allantoin

  2006cited by this paper
• Nischarin as a functional imidazoline (I1) receptor

  2006cited by this paper
• Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats

  2005cited by this paper
• Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R

  2005cited by this paper
• Activation of imidazoline receptor by agmatine to lower plasma glucose in streptozotocin-induced diabetic rats.

  2004cited by this paper
• Imidazoline binding sites and their ligands: An overview of the different chemical structures

  2004cited by this paper
• Effects of the imidazoline ligands efaroxan and KU14R on blood glucose homeostasis in the mouse.

  2002cited by this paper
• Dietary fiber suppresses elevations of uric acid and allantoin in serum and urine induced by dietary RNA and increases its excretion to feces in rats.

  2002cited by this paper
• Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential as targets for the development of new insulin secretagogues?

  2001cited by this paper
• Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.

  2001cited by this paper
• Kinetics of allantoin metabolism in sheep

  2000cited by this paper
• Imidazolines and Pancreatic Hormone Secretion a

  1999cited by this paper
• Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets

  1999cited by this paper
• 'Seeing through a glass darkly': casting light on imidazoline 'I' sites.

  1998cited by this paper
• Characterisation of new efaroxan derivatives for use in purification of imidazoline-binding sites.

  1998cited by this paper
• Postprandial hyperglycaemia and alpha-glucosidase inhibitors.

  1998cited by this paper
• Postprandial hyperglycaemia and α-glucosidase inhibitors

  1998cited by this paper
• Imidazoline receptors.

  1997cited by this paper
• Glibenclamide, an ATP-sensitive K+ channel blocker, inhibits cardiac cAMP-activated Cl- conductance.

  1995cited by this paper
• I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling.

  1995cited by this paper
• I1‐Imidazoline Receptors

  1995cited by this paper
• The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1‐ and I2‐sites

  1994cited by this paper
• Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non‐adrenoceptor idazoxan binding sites

  1993cited by this paper
• The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells

  1991cited by this paper
• The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.

  1991cited by this paper
• Quantitative Determination of Allantoin in Dioscorea Rhizome and an Oriental Pharmaceutical Preparation, Hachimi-Gan, by High-Performance Liquid Chromatography

  1989cited by this paper
• Allantoin excretion in the rat

  1973cited by this paper

• An overview of the nutritional composition, bioactivities and applications of Chinese yam (Dioscoreas Oppositae)

  2025cites this paper
• A Frontier Review of Nutraceutical Chinese Yam

  2024cites this paper
• Protective Effects of Allantoin on Neural Cells of Hippocampal Region and Cognitive Function in a Mouse Model of Temporal Lobe Epilepsy

  2024cites this paper
• Evaluation of the in vitro and in vivo genotoxicity of a Dioscorea Rhizome water extract

  2021cites this paper
• A 13-week subchronic toxicity study of a Dioscorea Rhizome water extract in rats.

  2020cites this paper
• Hypoglicemic and Antioxidant Activity of Petiveria alliacea in Diabetic Rat Models

  2020cites this paper
• Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism

  2019cites this paper
• Allantoin ameliorates chemically-induced pancreatic β-cell damage through activation of the imidazoline I3 receptors

  2015cites this paper
• Canavanine induces insulin release via activation of imidazoline I3 receptors

  2015cites this paper
• The gut microbiota and inflammatory bowel disease

  year unknowncites this paper